Funding and clinical trial-based barriers must be addressed to ensure success on the path to developing a DMT for Parkinson’s.

Add Yahoo as a preferred source to see more of our stories on Google. Scientists, using artificial intelligence (AI), have linked these bacterial changes to cognitive decline – which includes memory ...

Researchers have discovered a new biomarker for Parkinson's disease. A misfolded protein facilitates reliable diagnosis even in the early stages of Parkinson's disease in body fluids. Parkinson's ...

A misfolded protein facilitates reliable diagnosis even in the early stages of Parkinson’s disease in body fluids. Parkinson's disease is a neurodegenerative disorder that is usually diagnosed in its ...

A growing body of research into Parkinson’s disease is challenging the assumption that the condition looks the same in every ...

Changes in the bacteria found in the mouth and gut of Parkinson’s disease patients could act as an early warning sign that their symptoms are worsening, new research suggests. Scientists, using ...

Professor Klaus Gewert is founding and managing director at PRODI – Center for Protein Diagnostics at Ruhr University Bochum – and CEO of the company betaSENSE. Parkinson’s disease is a ...